Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
IgA nephropathy(IgAN) is the highest incidence of kidney pathology in the primary
nephropathy. In terms of differences in prognosis, severe IgA nephropathy,one of the most
main primary renal disease,could cause the uremia. It will be significant that early
indicators of prognosis and early intervention can be normalized and the scientific criteria
for judging the efficacy of great clinical can be established. The subject based on the past
study,literature research and various treatment will take the method of multi-center,
double-blind, randomized, control to investigate the standard treatment of severe IgA
nephropathy. Otherwise the uniformity and objectivity of Traditional Chinese Medicine (TCM)
will be improved by the standardization of TCM research based on the epidemiological
investigation and statistical analysis. The subject will determine the efficacy of more
sensitive biomarkers and establish more scientific criteria for judging the effect with the
application of urine proteomics and metabolomics technologies in order to operate in the
formation of the standardization program of the treatment of severe IgA nephropathy with the
Integrative medicine of TCM.
Phase:
N/A
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine